Skip to content

Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis

Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02047851
Enrollment
10
Registered
2014-01-28
Start date
2014-10-31
Completion date
2018-05-09
Last updated
2019-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthralgia, Psoriasis

Brief summary

The purpose of this study is to determine whether acupuncture is helpful for patients with joint pain associated with psoriasis

Detailed description

In this study, patients with psoriasis and joint pain will receive either real acupuncture or sham acupuncture to see if acupuncture can be an effective treatment of joint pain in patients with psoriasis.

Interventions

OTHERAcupuncture

Patients are randomized to real acupuncture or sham acupuncture if they are in the intervention group

Sponsors

Aage Bangs Fond
CollaboratorOTHER
University Hospital, Gentofte, Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Plaque psoriasis * Pain from at least two peripheral joints and/or inflammatory back pain * No or stabile treatment of the psoriasis the last 3 months * No or stabile pain treatment the last 3 months * Oral and written information given * Written consent signed

Exclusion criteria

* Arthritis with Ultrasound verified intra articular fluid og clinical verified joint swelling * Pregnancy og breastfeeding * Previous treatments with acupuncture * Treatment with anticoagulants (vitamin K-antagonists, low molecular weight heparin, unfractionated heparin, direct thrombin inhibitors, direct factor Xa inhibitors) * Unwilling to follow protocol

Design outcomes

Primary

MeasureTime frameDescription
Pain measured on the VASFrom day 0 to day 60 of the trialPatients will record their level of pain in a journal each day, ranging from 0 to 10 where 0 is no pain and 10 is worst possible pain.
Improvement in life quality measured with the DLQI (Dermatology Life Quality Index)From day 0 to day 60 of the study periodOn day 0, 30 and 60 the patients will fill out a simple questionnaire with 10 questions concerning their life quality

Secondary

MeasureTime frameDescription
Approvement in skin lesionsFrom day 0 to day 60 of the study periodAt each of the 3 control visits the patients will be asked if their psoriatic skin lesions have become better from the acupuncture, and if they say yes, how much better? Minimal improvement, moderate improvement og big improvement?

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026